Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2016, XLI/246: 275-278 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2016, XLI/246: 275-278

Title: Estimation of cardiovascular risk in patients with metabolic syndrome 

Authors: Godala M, Materek-Kuśmierkiewicz I, Moczulski D, Szatko F, Gaszyńska E, Kowalski J. 

More details

03/246

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Estimation of cardiovascular risk in patients with metabolic syndrome


Godala M1, Materek-Kuśmierkiewicz I2, Moczulski D2, Szatko F3, Gaszyńska E3, Kowalski J4.

Medical University of Lodz, Poland: 1Department of Hygiene of Nutrition and Epidemiology, 2Department of Internal Diseases and Nephrodiabetology, 3Department of Hygiene and Health Promotion, 4Department of Internal Medicine and Cardiac Rehabilitation

Metabolic syndrome (MS) is a coexistence of metabolic risk factors affecting development of cardiovascular diseases. The SCORE system estimates fatal cardiovascular disease events over a ten-year period.
The aim of the study
was to estimate cardiovascular risk in patients with symptoms of MS.
Material and methods
. The study included 268 patients with symptoms of MS according to International Diabetes Federation criteria (2005), 136 men and 132 women, mean age 59,62±9,21 years. The cardiovascular risk was estimated on based of pulse pressure and SCORE table in these patients.
Results
. In subjects with MS the mean value of pulse pressure (pp) was 58,96±2,34 mmHg, increased values of pp was found in 33,21% subjects with MS. High and very high cardiovascular death risk occurred in 80,97% subjects with MS, significantly more often in men than women.
Conclusions
. In majority of patients with MS high cardiovascular risk was found. In every three subjects with MS high pulse pressure was stated.

Key words: metabolic syndrome, SCORE, pulse pressure

Pol Med J, 2016; XLI (246); 275–278